Global Cytomegalovirus Infection Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Cytomegalovirus Infection
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Cytomegalovirus Infection by Type
- 1.3.1 Overview: Global Cytomegalovirus Infection Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Cytomegalovirus Infection Consumption Value Market Share by Type in 2023
- 1.3.3 Cidofovir
- 1.3.4 Foscarnet
- 1.3.5 Valganciclovir
- 1.3.6 Ganciclovir
- 1.4 Global Cytomegalovirus Infection Market by Application
- 1.4.1 Overview: Global Cytomegalovirus Infection Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospitals
- 1.4.3 Retail Pharmacies
- 1.4.4 Online Pharmacies
- 1.5 Global Cytomegalovirus Infection Market Size & Forecast
- 1.6 Global Cytomegalovirus Infection Market Size and Forecast by Region
- 1.6.1 Global Cytomegalovirus Infection Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Cytomegalovirus Infection Market Size by Region, (2019-2030)
- 1.6.3 North America Cytomegalovirus Infection Market Size and Prospect (2019-2030)
- 1.6.4 Europe Cytomegalovirus Infection Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Cytomegalovirus Infection Market Size and Prospect (2019-2030)
- 1.6.6 South America Cytomegalovirus Infection Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Cytomegalovirus Infection Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Cytomegalovirus Infection Product and Solutions
- 2.1.4 Roche Cytomegalovirus Infection Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Roche Recent Developments and Future Plans
- 2.2 GlaxoSmithKline
- 2.2.1 GlaxoSmithKline Details
- 2.2.2 GlaxoSmithKline Major Business
- 2.2.3 GlaxoSmithKline Cytomegalovirus Infection Product and Solutions
- 2.2.4 GlaxoSmithKline Cytomegalovirus Infection Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 GlaxoSmithKline Recent Developments and Future Plans
- 2.3 Vical
- 2.3.1 Vical Details
- 2.3.2 Vical Major Business
- 2.3.3 Vical Cytomegalovirus Infection Product and Solutions
- 2.3.4 Vical Cytomegalovirus Infection Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Vical Recent Developments and Future Plans
- 2.4 AiCuris Anti-Infective Cures
- 2.4.1 AiCuris Anti-Infective Cures Details
- 2.4.2 AiCuris Anti-Infective Cures Major Business
- 2.4.3 AiCuris Anti-Infective Cures Cytomegalovirus Infection Product and Solutions
- 2.4.4 AiCuris Anti-Infective Cures Cytomegalovirus Infection Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 AiCuris Anti-Infective Cures Recent Developments and Future Plans
- 2.5 ViroPharma
- 2.5.1 ViroPharma Details
- 2.5.2 ViroPharma Major Business
- 2.5.3 ViroPharma Cytomegalovirus Infection Product and Solutions
- 2.5.4 ViroPharma Cytomegalovirus Infection Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 ViroPharma Recent Developments and Future Plans
- 2.6 Chimerix
- 2.6.1 Chimerix Details
- 2.6.2 Chimerix Major Business
- 2.6.3 Chimerix Cytomegalovirus Infection Product and Solutions
- 2.6.4 Chimerix Cytomegalovirus Infection Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Chimerix Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Cytomegalovirus Infection Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Cytomegalovirus Infection by Company Revenue
- 3.2.2 Top 3 Cytomegalovirus Infection Players Market Share in 2023
- 3.2.3 Top 6 Cytomegalovirus Infection Players Market Share in 2023
- 3.3 Cytomegalovirus Infection Market: Overall Company Footprint Analysis
- 3.3.1 Cytomegalovirus Infection Market: Region Footprint
- 3.3.2 Cytomegalovirus Infection Market: Company Product Type Footprint
- 3.3.3 Cytomegalovirus Infection Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Cytomegalovirus Infection Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Cytomegalovirus Infection Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Cytomegalovirus Infection Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Cytomegalovirus Infection Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Cytomegalovirus Infection Consumption Value by Type (2019-2030)
- 6.2 North America Cytomegalovirus Infection Consumption Value by Application (2019-2030)
- 6.3 North America Cytomegalovirus Infection Market Size by Country
- 6.3.1 North America Cytomegalovirus Infection Consumption Value by Country (2019-2030)
- 6.3.2 United States Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 6.3.3 Canada Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Cytomegalovirus Infection Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Cytomegalovirus Infection Consumption Value by Type (2019-2030)
- 7.2 Europe Cytomegalovirus Infection Consumption Value by Application (2019-2030)
- 7.3 Europe Cytomegalovirus Infection Market Size by Country
- 7.3.1 Europe Cytomegalovirus Infection Consumption Value by Country (2019-2030)
- 7.3.2 Germany Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 7.3.3 France Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 7.3.5 Russia Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 7.3.6 Italy Cytomegalovirus Infection Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Cytomegalovirus Infection Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Cytomegalovirus Infection Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Cytomegalovirus Infection Market Size by Region
- 8.3.1 Asia-Pacific Cytomegalovirus Infection Consumption Value by Region (2019-2030)
- 8.3.2 China Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 8.3.3 Japan Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 8.3.5 India Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 8.3.7 Australia Cytomegalovirus Infection Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Cytomegalovirus Infection Consumption Value by Type (2019-2030)
- 9.2 South America Cytomegalovirus Infection Consumption Value by Application (2019-2030)
- 9.3 South America Cytomegalovirus Infection Market Size by Country
- 9.3.1 South America Cytomegalovirus Infection Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Cytomegalovirus Infection Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Cytomegalovirus Infection Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Cytomegalovirus Infection Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Cytomegalovirus Infection Market Size by Country
- 10.3.1 Middle East & Africa Cytomegalovirus Infection Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Cytomegalovirus Infection Market Size and Forecast (2019-2030)
- 10.3.4 UAE Cytomegalovirus Infection Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Cytomegalovirus Infection Market Drivers
- 11.2 Cytomegalovirus Infection Market Restraints
- 11.3 Cytomegalovirus Infection Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Cytomegalovirus Infection Industry Chain
- 12.2 Cytomegalovirus Infection Upstream Analysis
- 12.3 Cytomegalovirus Infection Midstream Analysis
- 12.4 Cytomegalovirus Infection Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Cytomegalovirus Infection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection can spread easily through saliva or urine and the people infected with the CMV may have the virus in their saliva or urine for months. The disease can be transmitted from pregnant women to the baby during the delivery. Blood transfusion and infected organ transplant is yet another mode of disease transmission.
The key factor responsible for growth of cytomegalovirus infection is increasing public awareness related to herpes virus infections which is fueling the diagnosis rate in North America and Europe. North America was observed as the largest market for cytomegalovirus infection treatment followed by Europe. Asia Pacific was anticipated to grow at a fastest CAGR during the forecast period. The key factors assisting the growth of Asia Pacific cytomegalovirus infection treatment market are the rising awareness associated with the rare diseases, developing healthcare infrastructure, high disposable income and government support for novel treatment against rare genetic diseases.
The Global Info Research report includes an overview of the development of the Cytomegalovirus Infection industry chain, the market status of Hospitals (Cidofovir, Foscarnet), Retail Pharmacies (Cidofovir, Foscarnet), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cytomegalovirus Infection.
Regionally, the report analyzes the Cytomegalovirus Infection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cytomegalovirus Infection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cytomegalovirus Infection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cytomegalovirus Infection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cidofovir, Foscarnet).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cytomegalovirus Infection market.
Regional Analysis: The report involves examining the Cytomegalovirus Infection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cytomegalovirus Infection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cytomegalovirus Infection:
Company Analysis: Report covers individual Cytomegalovirus Infection players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cytomegalovirus Infection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Cytomegalovirus Infection. It assesses the current state, advancements, and potential future developments in Cytomegalovirus Infection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cytomegalovirus Infection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cytomegalovirus Infection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Cidofovir
Foscarnet
Valganciclovir
Ganciclovir
Market segment by Application
Hospitals
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Roche
GlaxoSmithKline
Vical
AiCuris Anti-Infective Cures
ViroPharma
Chimerix
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cytomegalovirus Infection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cytomegalovirus Infection, with revenue, gross margin and global market share of Cytomegalovirus Infection from 2019 to 2024.
Chapter 3, the Cytomegalovirus Infection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cytomegalovirus Infection market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cytomegalovirus Infection.
Chapter 13, to describe Cytomegalovirus Infection research findings and conclusion.